Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-10 08:45 am Purchase |
2025-02-28 | 13G | AEON Biopharma, Inc. AEON |
Alta Partners LLC | 629,614 6.230% |
629,614 (New Position) |
Filing History |
| 2025-03-07 4:01 pm Purchase |
2024-07-25 | 13D | AEON Biopharma, Inc. AEON |
Robert J Palmisano | 2,265,000 5.700% |
2,233,542 (+7100.00%) |
Filing History |
| 2025-03-03 1:51 pm Purchase |
2025-02-26 | 13G | AEON Biopharma, Inc. AEON |
Dauntless Investment Group, LLC | 108,224 9.700% |
108,224 (New Position) |
Filing History |
| 2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | AEON Biopharma, Inc. AEON |
Blue Owl Capital Holdings LP | 42,352 3.810% |
-4,053 (-8.73%) |
Filing History |
| 2025-02-14 4:44 pm Sale |
2024-12-31 | 13G | AEON Biopharma, Inc. AEON |
Polar Asset Management Partners Inc. | 38,371 6.900% |
-12,671 (-24.82%) |
Filing History |
| 2025-01-22 4:02 pm Purchase |
2024-07-25 | 13D | AEON Biopharma, Inc. AEON |
Robert J Palmisano | 31,458 5.700% |
31,458 (New Position) |
Filing History |
| 2025-01-13 4:14 pm Purchase |
2025-01-06 | 13G | AEON Biopharma, Inc. AEON |
S.H.N. Financial Investments Ltd. | 75,000 6.000% |
75,000 (New Position) |
Filing History |
| 2025-01-13 4:08 pm Purchase |
2025-01-06 | 13G | AEON Biopharma, Inc. AEON |
L1 Capital Global Opportunities Master Fund, Ltd. | 124,444 9.990% |
124,444 (New Position) |
Filing History |
| 2025-01-08 4:15 pm Purchase |
2025-01-06 | 13G | AEON Biopharma, Inc. AEON |
BIGGER CAPITAL FUND L P | 68,056 6.100% |
68,056 (New Position) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | AEON Biopharma, Inc. AEON |
Blue Owl Capital Holdings LP | 46,406 8.450% |
46,406 (New Position) |
Filing History |
| 2024-02-14 1:46 pm Purchase |
2023-12-31 | 13G | AEON Biopharma, Inc. AEON |
Polar Asset Management Partners Inc. | 51,042 9.900% |
51,042 (New Position) |
Filing History |
| 2024-02-14 09:00 am Unchanged |
2023-12-31 | 13G | AEON Biopharma, Inc. AEON |
Empyrean Capital Partners, LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-08-22 4:37 pm Sale |
2023-08-11 | 13D | AEON Biopharma, Inc. AEON |
Strathspey Crown Holdings Group LLC | 28,219 5.470% |
-102,619 (-78.43%) |
Filing History |
| 2023-07-31 4:45 pm Purchase |
2023-07-21 | 13D | AEON Biopharma, Inc. AEON |
Strathspey Crown Holdings Group LLC | 130,838 25.400% |
130,838 (New Position) |
Filing History |
| 2023-07-31 4:15 pm Purchase |
2023-07-27 | 13G | AEON Biopharma, Inc. AEON |
Atalaya Capital Management LP | 51,042 9.890% |
51,042 (New Position) |
Filing History |
| 2023-07-28 07:55 am Purchase |
2023-07-28 | 13D | AEON Biopharma, Inc. AEON |
Daewoong Co. Ltd | 91,356 23.980% |
91,356 (New Position) |
Filing History |
| 2023-07-20 11:32 am Unchanged |
2023-07-18 | 13G | Priveterra Acquisition Corp. PMGM |
Saba Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-06-12 4:42 pm Sale |
2023-05-31 | 13G | Priveterra Acquisition Corp. PMGM |
Glazer Capital, LLC | 59,166 2.950% |
-168,378 (-74.00%) |
Filing History |
| 2023-03-10 4:33 pm Purchase |
2023-02-28 | 13G | Priveterra Acquisition Corp. PMGM |
Glazer Capital, LLC | 227,544 11.360% |
227,544 (New Position) |
Filing History |
| 2021-02-22 08:30 am Purchase |
2021-02-11 | 13G | Priveterra Acquisition Corp. PMGMU |
Empyrean Capital Partners, LP | 1,400,000 5.100% |
1,400,000 (New Position) |
Filing History |